Bharat Biotech seeks drug regulator’s nod for Incovacc’s phase-III study in five-18 age group Read more
Bharat Biotech completes clinical development for phase-III trials and booster doses for BBV154 intra-nasal COVID vaccine Read more
Covaxin demonstrates persistence of immunity and impact of third dose of inactivated COVID-19 vaccine against emerging variants Read more
Ocugen announces positive results for COVID-19 vaccine trial for children aged two-18 years Read more
ICMR study finds Covaxin booster dose improves effectiveness against Delta, Omicron variants Read more